149 related articles for article (PubMed ID: 9321821)
1. Hemodynamic effects of intracoronary VEGF delivery: evidence of tachyphylaxis and NO dependence of response.
Lopez JJ; Laham RJ; Carrozza JP; Tofukuji M; Sellke FW; Bunting S; Simons M
Am J Physiol; 1997 Sep; 273(3 Pt 2):H1317-23. PubMed ID: 9321821
[TBL] [Abstract][Full Text] [Related]
2. Spatial heterogeneity in VEGF-induced vasodilation: VEGF dilates microvessels but not epicardial and systemic arteries and veins.
Laham RJ; Li J; Tofukuji M; Post M; Simons M; Sellke FW
Ann Vasc Surg; 2003 May; 17(3):245-52. PubMed ID: 12704544
[TBL] [Abstract][Full Text] [Related]
3. VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts.
Hariawala MD; Horowitz JR; Esakof D; Sheriff DD; Walter DH; Keyt B; Isner JM; Symes JF
J Surg Res; 1996 Jun; 63(1):77-82. PubMed ID: 8661176
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor causes pulmonary vasodilation through activation of the phosphatidylinositol-3-kinase-nitric oxide pathway in the late-gestation ovine fetus.
Grover TR; Zenge JP; Parker TA; Abman SH
Pediatr Res; 2002 Dec; 52(6):907-12. PubMed ID: 12438669
[TBL] [Abstract][Full Text] [Related]
5. VEGF administration in chronic myocardial ischemia in pigs.
Lopez JJ; Laham RJ; Stamler A; Pearlman JD; Bunting S; Kaplan A; Carrozza JP; Sellke FW; Simons M
Cardiovasc Res; 1998 Nov; 40(2):272-81. PubMed ID: 9893720
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor administration in chronic myocardial ischemia.
Harada K; Friedman M; Lopez JJ; Wang SY; Li J; Prasad PV; Pearlman JD; Edelman ER; Sellke FW; Simons M
Am J Physiol; 1996 May; 270(5 Pt 2):H1791-802. PubMed ID: 8928888
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of intracoronary or intravenous VEGF165 in a pig model of chronic myocardial ischemia.
Sato K; Wu T; Laham RJ; Johnson RB; Douglas P; Li J; Sellke FW; Bunting S; Simons M; Post MJ
J Am Coll Cardiol; 2001 Feb; 37(2):616-23. PubMed ID: 11216988
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor/vascular permeability factor produces nitric oxide-dependent hypotension. Evidence for a maintenance role in quiescent adult endothelium.
Horowitz JR; Rivard A; van der Zee R; Hariawala M; Sheriff DD; Esakof DD; Chaudhry GM; Symes JF; Isner JM
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2793-800. PubMed ID: 9409257
[TBL] [Abstract][Full Text] [Related]
9. Role for nitric oxide in the hyperpermeability and hemodynamic changes induced by intravenous VEGF.
Tilton RG; Chang KC; LeJeune WS; Stephan CC; Brock TA; Williamson JR
Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):689-96. PubMed ID: 10067972
[TBL] [Abstract][Full Text] [Related]
10. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs.
Banai S; Jaklitsch MT; Shou M; Lazarous DF; Scheinowitz M; Biro S; Epstein SE; Unger EF
Circulation; 1994 May; 89(5):2183-9. PubMed ID: 7514110
[TBL] [Abstract][Full Text] [Related]
11. Enhanced microvascular relaxations to VEGF and bFGF in chronically ischemic porcine myocardium.
Sellke FW; Wang SY; Stamler A; Lopez JJ; Li J; Li J; Simons M
Am J Physiol; 1996 Aug; 271(2 Pt 2):H713-20. PubMed ID: 8770115
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide does not mediate coronary vasodilation by isoflurane.
Crystal GJ; Kim SJ; Salem MR; Khoury E; Gurevicius J
Anesthesiology; 1994 Jul; 81(1):209-20. PubMed ID: 8042788
[TBL] [Abstract][Full Text] [Related]
13. Substantially attenuated hemodynamic responses to Escherichia coli-derived vascular endothelial growth factor given by intravenous infusion compared with bolus injection.
Yang R; Bunting S; Ko A; Keyt BA; Modi NB; Zioncheck TF; Ferrara N; Jin H
J Pharmacol Exp Ther; 1998 Jan; 284(1):103-10. PubMed ID: 9435167
[TBL] [Abstract][Full Text] [Related]
14. Effects of vascular endothelial growth factor on hemodynamics and cardiac performance.
Yang R; Thomas GR; Bunting S; Ko A; Ferrara N; Keyt B; Ross J; Jin H
J Cardiovasc Pharmacol; 1996 Jun; 27(6):838-44. PubMed ID: 8761851
[TBL] [Abstract][Full Text] [Related]
15. Effects of verapamil and nitroglycerin on coronary and systemic hemodynamics in conscious dogs.
Adachi H; Tomoike H; Nishijima H; Hayashi Y; Yamada A; Nakamura M
J Pharmacol Exp Ther; 1987 Jun; 241(3):1072-8. PubMed ID: 3110406
[TBL] [Abstract][Full Text] [Related]
16. Contribution of nitric oxide to coronary vasodilation during hypercapnic acidosis.
Gurevicius J; Salem MR; Metwally AA; Silver JM; Crystal GJ
Am J Physiol; 1995 Jan; 268(1 Pt 2):H39-47. PubMed ID: 7530920
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic effects of scatter factor in conscious rats.
Yang R; Bunting S; Ko A; Schwall R; Jin H
J Cardiovasc Pharmacol; 1997 Sep; 30(3):294-301. PubMed ID: 9300311
[TBL] [Abstract][Full Text] [Related]
18. Assessment of coronary conductance and resistance vessel reactivity in response to nitroglycerin, ergonovine and adenosine: in vivo studies with simultaneous intravascular two-dimensional and Doppler ultrasound.
Sudhir K; MacGregor JS; Barbant SD; Foster E; Fitzgerald PJ; Chatterjee K; Yock PG
J Am Coll Cardiol; 1993 Apr; 21(5):1261-8. PubMed ID: 8459086
[TBL] [Abstract][Full Text] [Related]
19. Flow-mediated dilation attenuates constriction of large coronary arteries to serotonin.
Lamping KG; Dole WP
Am J Physiol; 1988 Dec; 255(6 Pt 2):H1317-24. PubMed ID: 3144185
[TBL] [Abstract][Full Text] [Related]
20. Intracoronary intermedin 1-47 augments cardiac perfusion and function in anesthetized pigs: role of calcitonin receptors and beta-adrenoreceptor-mediated nitric oxide release.
Grossini E; Molinari C; Mary DA; Uberti F; Caimmi PP; Vacca G
J Appl Physiol (1985); 2009 Oct; 107(4):1037-50. PubMed ID: 19696365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
